2016
DOI: 10.1016/s0735-1097(16)30239-x
|View full text |Cite
|
Sign up to set email alerts
|

Incidence, Predictors and Impact of Major Bleeding in Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement With Bivalirudin or Unfractionated Heparin: From the Effect of Bivalirudin on Aortic Valve Intervention Outcomes (Bravo) Trial

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles